Drug Name Stems and Suffixes, Decoded
Educational only, not medical advice. This guide explains general US pharmacy-technician topics. Follow your training, your pharmacist, your state board and the official references for real patients.
Generic drug names look random until you notice the endings. Lisinopril, enalapril and ramipril all end in -pril and all are ACE inhibitors. That is not a coincidence: in the US, generic names are assigned by the United States Adopted Names (USAN) Council, which builds new names from approved stems that signal a drug's chemical or pharmacologic family. Learning the common stems is one of the fastest ways to handle the generic-name and drug-class items on the PTCE. This guide explains how stems work, lists the ones worth memorizing, and covers the exceptions that make stems a clue rather than a rule.
How USAN stems work
The USAN Council works alongside the FDA and coordinates with the World Health Organization's International Nonproprietary Names (INN) program, so a US generic name usually matches the international one. Its naming guidelines make a few points that matter for studying:
- Drugs that share a stem are related, usually by mechanism of action, chemical structure or both.
- Most stems are suffixes, but a few sit at the start of a name (cef- for cephalosporins) or in the middle (-grel- appears inside ticagrelor).
- The rest of the name is a fanciful prefix chosen to be distinctive. It carries no meaning, so "lisino-" and "enala-" tell you nothing.
- The AMA's stem list is not exhaustive. New stems are added each year, and some older definitions get revised.
Stems worth memorizing
| Stem | Class | Generic examples |
|---|---|---|
| -olol | beta blockers | metoprolol, atenolol, propranolol |
| -pril | ACE inhibitors | lisinopril, enalapril, benazepril |
| -sartan | angiotensin II receptor blockers | losartan, valsartan, irbesartan |
| -vastatin | statins (HMG-CoA reductase inhibitors) | atorvastatin, simvastatin, rosuvastatin |
| -dipine | calcium channel blockers (nifedipine type) | amlodipine, nifedipine, felodipine |
| -parin / -xaban | heparin derivatives / factor Xa inhibitors | enoxaparin, dalteparin / apixaban, rivaroxaban |
| -grel- | platelet aggregation inhibitors | clopidogrel, prasugrel, ticagrelor |
| -prazole | proton pump inhibitors (antiulcer) | omeprazole, pantoprazole, esomeprazole |
| -tidine | H2-receptor antagonists | famotidine, cimetidine, nizatidine |
| -gliptin | DPP-4 inhibitors | sitagliptin, linagliptin, saxagliptin |
| -gliflozin | SGLT2 inhibitors | empagliflozin, dapagliflozin, canagliflozin |
| -glutide | GLP-1 receptor agonists | liraglutide, dulaglutide, semaglutide |
| -cillin | penicillins | amoxicillin, ampicillin, dicloxacillin |
| cef- | cephalosporins | cephalexin, cefdinir, ceftriaxone |
| -cycline | tetracyclines | doxycycline, minocycline, tetracycline |
| -conazole | systemic azole antifungals | fluconazole, itraconazole, voriconazole |
| -vir | antivirals | acyclovir, valacyclovir, oseltamivir |
| -azepam / -azolam | benzodiazepines | lorazepam, diazepam / alprazolam, midazolam |
| -lukast | leukotriene receptor antagonists | montelukast, zafirlukast |
| -afil | PDE5 inhibitors | sildenafil, tadalafil |
| -mab | monoclonal antibodies | adalimumab, infliximab, trastuzumab |
| -tinib | tyrosine kinase inhibitors | imatinib, erlotinib, ibrutinib |
Two spelling notes: some older cephalosporins, such as cephalexin, are spelled "ceph-" in the US rather than "cef-," and the -vir family keeps growing longer, more specific stems, such as -capavir for viral capsid inhibitors. When a name ends in -vir, think antiviral first.
Caveat 1: look-alike endings that are not the same stem
The biggest trap is assuming that any name with a familiar ending belongs to that class. Read the whole stem, not just the last few letters.
- "-azole" is not one class. Fluconazole (-conazole) is an antifungal, omeprazole (-prazole) is a proton pump inhibitor, metronidazole is an antibacterial and antiprotozoal, and aripiprazole and brexpiprazole are antipsychotics even though they end in "-prazole."
- "-statin" vs "-vastatin." Every cholesterol-lowering statin ends in -vastatin. Nystatin ends in "-statin" but is an antifungal.
- "-pine" is everywhere. -dipine marks calcium channel blockers, but olanzapine, quetiapine and clozapine are antipsychotics, carbamazepine is an anticonvulsant and mirtazapine is an antidepressant.
- "-tidine" vs "-tadine." Famotidine is an H2 blocker for stomach acid; loratadine and desloratadine are H1 antihistamines for allergies.
- "-oxetine." Fluoxetine and duloxetine are antidepressants, but atomoxetine, with the same ending, is approved for ADHD.
- "-mycin" covers several classes. Azithromycin and erythromycin are macrolides, tobramycin is an aminoglycoside (as is gentamicin, spelled -micin), and vancomycin is a glycopeptide.
Caveat 2: drugs that skip the stem
Stems only work for drugs named under the system, and many older or unusual drugs do not follow one.
- Older drugs predate the stems: warfarin, digoxin and aspirin carry no class stem you can use.
- Same class, different ending. Verapamil and diltiazem are calcium channel blockers without -dipine; they anchor their own, smaller stems (-pamil and -tiazem). Labetalol (-alol) and carvedilol (-dilol) are beta blockers that also block alpha receptors. Glyburide is a sulfonylurea spelled with "gly-" while glipizide and glimepiride use "gli-."
- Not every antiviral ends in -vir. Amantadine, zidovudine and lamivudine are antivirals.
- Benzodiazepine exceptions. Chlordiazepoxide and clobazam are benzodiazepines without -azepam or -azolam.
Caveat 3: stems change over time
Naming schemes are revised when a stem gets crowded. By 2021 more than 800 monoclonal antibody names had been coined with -mab, so the USAN Council adopted a revised scheme, effective December 2021, that gives new antibodies different suffixes; for example, -tug is used for unmodified full-length antibodies and -bart for "artificial" engineered ones. Names already adopted keep their -mab ending, so -mab will remain on pharmacy shelves for years.
Caveat 4: a stem tells you the class, not the use
A stem describes mechanism or structure, not the reason a patient takes the drug. Propranolol is a beta blocker that is also labeled for migraine prevention and essential tremor, and some SGLT2 inhibitors are labeled for heart failure and kidney disease as well as diabetes. Use the stem to identify the class, then let the pharmacist handle questions about why a drug was prescribed.
Look-alike names also cause real dispensing errors. The FDA's Name Differentiation Project and ISMP's List of Confused Drug Names promote "Tall Man" lettering, such as hydrALAZINE and hydrOXYzine, to make similar names easier to tell apart on labels, shelves and screens. Shared stems make names look alike, so always check the full name, strength and dosage form.
Key takeaways
- USAN stems group drugs by mechanism or structure; the fanciful prefix carries no meaning.
- Most stems are suffixes, but cef- is a prefix and -grel- can sit inside a name.
- Read the whole stem: -conazole, -prazole and metronidazole all end in "-azole" but belong to different classes.
- Older drugs such as warfarin follow no stem, and some class members use a less familiar one (verapamil -pamil and diltiazem -tiazem instead of -dipine).
- New monoclonal antibodies named after December 2021 use new suffixes such as -tug and -bart.
- Shared stems make names look alike, so verify the full name every time.
Quick check
Q1. What class is valsartan?
Answer: An angiotensin II receptor blocker (ARB). The -sartan stem marks angiotensin II receptor antagonists.
Q2. Pantoprazole and aripiprazole both end in "-prazole." Are they in the same class?
Answer: No. Pantoprazole is a proton pump inhibitor, while aripiprazole is an antipsychotic; the shared ending is a look-alike, not a shared class.
Q3. Which drug is a calcium channel blocker even though it lacks the -dipine stem: diltiazem, doxazosin or dapagliflozin?
Answer: Diltiazem. Doxazosin is an alpha blocker and dapagliflozin is an SGLT2 inhibitor (-gliflozin).
Practice decoding stems in Pillworks Idle.
Sources
- American Medical Association — United States Adopted Names approved stems
- American Medical Association — United States Adopted Names naming guidelines
- American Medical Association — USAN monoclonal antibody naming
- FDA — FDA Name Differentiation Project (Tall Man lettering)
- ISMP — List of Confused Drug Names (2024)
- PTCB — PTCE Job Analysis Study and the content outline effective January 6, 2026